Selective oxidative protection leads to tissue topological changes orchestrated by macrophage during ulcerative colitis
Download from source ↗Dataset overview
Selective oxidative protection leads to tissue topological changes orchestrated by macrophage during ulcerative colitis.
Abstract
Ulcerative colitis is a chronic inflammatory bowel disorder with cellular heterogeneity. To understand the composition and spatial changes of the ulcerative colitis ecosystem, here we use imaging mass cytometry and single-cell RNA sequencing to depict the single-cell landscape of the human colon ecosystem. We find tissue topological changes featured with macrophage disappearance reaction in the ulcerative colitis region, occurring only for tissue-resident macrophages. Reactive oxygen species levels are higher in the ulcerative colitis region, but reactive oxygen species scavenging enzyme SOD2 is barely detected in resident macrophages, resulting in distinct reactive oxygen species vulnerability for inflammatory macrophages and resident macrophages. Inflammatory macrophages replace resident macrophages and cause a spatial shift of TNF production during ulcerative colitis via a cytokine production network formed with T and B cells. Our study suggests components of a mechanism for the observed macrophage disappearance reaction of resident macrophages, providing mechanistic hints for macrophage disappearance reaction in other inflammation or infection situations.
doi:10.1038/s41467-023-39173-2 ↗ PMID 37344477 ↗ PMC10284839 ↗
Study facts
- Organism
- Homo sapiens
- Platform
- Illumina NextSeq 500
- Age group
- —
- Disease groups
- —
- Anatomical sites
- inflamed colon region, normal ascending colon, healthy control colon
Data availability
- Raw counts
- Processed matrix
- Analysis code
File types
MTXTSV
Files and samples
- filelist.txt ↗
- GSE231993_RAW.tar ↗
- GSM7307094_181045B-C-0816-barcodes.tsv.gz ↗
- GSM7307094_181045B-C-0816-features.tsv.gz ↗
- GSM7307094_181045B-C-0816-matrix.mtx.gz ↗
- GSM7307095_181045C-C-0911-barcodes.tsv.gz ↗
- GSM7307095_181045C-C-0911-features.tsv.gz ↗
- GSM7307095_181045C-C-0911-matrix.mtx.gz ↗
- GSM7307096_181045D-C-1025-2-barcodes.tsv.gz ↗
- GSM7307096_181045D-C-1025-2-features.tsv.gz ↗
- GSM7307096_181045D-C-1025-2-matrix.mtx.gz ↗
- GSM7307097_181045D-C-1025-1-barcodes.tsv.gz ↗
- GSM7307097_181045D-C-1025-1-features.tsv.gz ↗
- GSM7307097_181045D-C-1025-1-matrix.mtx.gz ↗
- GSM7307098_181045B-T-0816-barcodes.tsv.gz ↗
- GSM7307098_181045B-T-0816-features.tsv.gz ↗
- GSM7307098_181045B-T-0816-matrix.mtx.gz ↗
- GSM7307099_181045C-T-0911-barcodes.tsv.gz ↗
- GSM7307099_181045C-T-0911-features.tsv.gz ↗
- GSM7307099_181045C-T-0911-matrix.mtx.gz ↗
- GSM7307100_181045D-T-1025-2-barcodes.tsv.gz ↗
- GSM7307100_181045D-T-1025-2-features.tsv.gz ↗
- GSM7307100_181045D-T-1025-2-matrix.mtx.gz ↗
- GSM7307101_181045D-T-1025-1-barcodes.tsv.gz ↗
- GSM7307101_181045D-T-1025-1-features.tsv.gz ↗
- GSM7307101_181045D-T-1025-1-matrix.mtx.gz ↗
- GSM7307102_181045E-C-1101-1-barcodes.tsv.gz ↗
- GSM7307102_181045E-C-1101-1-features.tsv.gz ↗
- GSM7307102_181045E-C-1101-1-matrix.mtx.gz ↗
- GSM7307103_181045E-C-1101-2-barcodes.tsv.gz ↗
- GSM7307103_181045E-C-1101-2-features.tsv.gz ↗
- GSM7307103_181045E-C-1101-2-matrix.mtx.gz ↗
- GSM7307104_181045F-C-1108-3-barcodes.tsv.gz ↗
- GSM7307104_181045F-C-1108-3-features.tsv.gz ↗
- GSM7307104_181045F-C-1108-3-matrix.mtx.gz ↗
- GSM7307105_181045F-C-1108-4-barcodes.tsv.gz ↗
- GSM7307105_181045F-C-1108-4-features.tsv.gz ↗
- GSM7307105_181045F-C-1108-4-matrix.mtx.gz ↗
- index.html ↗
- Healthy control colon4
- Inflamed colon region4
- Normal ascending colon4
| Accession | Sample | Tissue | Molecule |
|---|---|---|---|
GSM7307094 |
UC-self control,rep1,scRNA_seq | Normal ascending colon | total RNA |
GSM7307095 |
UC-self control,rep2,scRNA_seq | Normal ascending colon | total RNA |
GSM7307096 |
UC-self control,rep3,scRNA_seq | Normal ascending colon | total RNA |
GSM7307097 |
UC-self control,rep4,scRNA_seq | Normal ascending colon | total RNA |
GSM7307098 |
UC,rep1,scRNA_seq | Inflamed colon region | total RNA |
GSM7307099 |
UC,rep2,scRNA_seq | Inflamed colon region | total RNA |
GSM7307100 |
UC,rep3,scRNA_seq | Inflamed colon region | total RNA |
GSM7307101 |
UC,rep4,scRNA_seq | Inflamed colon region | total RNA |
GSM7307102 |
HC,rep5,scRNA_seq | Healthy control colon | total RNA |
GSM7307103 |
HC,rep6,scRNA_seq | Healthy control colon | total RNA |
GSM7307104 |
HC,rep7,scRNA_seq | Healthy control colon | total RNA |
GSM7307105 |
HC,rep8,scRNA_seq | Healthy control colon | total RNA |
Strengths & limitations for reuse
Strengths
- Raw counts are advertised
- Processed matrices are advertised
- Analysis code is available
- Participant mapping is available
- Participant counts are documented
Limitations
- Not documented: cell metadata are advertised
Extraction evidence & provenance
Each extracted field is shown with the source excerpt and location used to resolve it.
Assay
| Field | Value | Evidence |
|---|---|---|
assay.assay_type |
10x Genomics droplet-based single-cell RNA sequencing |
The single cells were loaded into Chromium microfluidic chips with v3 chemistry, then barcoded with a 10× Chromium Controller Section |
assay.library_chemistry |
Chromium Single Cell v3 reagent kit |
sequencing libraries were constructed with reagents from a Chromium Single Cell v3 reagent kit Section |
assay.platform |
Illumina NextSeq 500 |
"instrument_model": "Illumina NextSeq 500" Section |
assay.reference_genome |
GRCh38 |
Assembly: GRCh38 Section |
assay.sequencing_type |
scrna_seq |
UC-self control,rep2,scRNA_seq Section |
Cohort
| Field | Value | Evidence |
|---|---|---|
cohort.non_ibd_controls |
4 |
Four healthy control subjects and 4 UC patients were enrolled Section |
cohort.study_design |
cross_sectional inferred |
For each of the 4 patients, 1 pinch biopsy specimen was collected from the inflamed colon region as the UC group, and 1 pinch biopsy specimen from the normal ascending colon of patients served as self-control Section |
cohort.total_participants |
8 |
Four healthy control subjects and 4 UC patients were enrolled Section |
cohort.ulcerative_colitis_participants |
4 |
Four healthy control subjects and 4 UC patients were enrolled Section |
Data_Assets
| Field | Value | Evidence |
|---|---|---|
data_assets.analysis_code |
True |
All the codes related to the analysis are publicly available at https://github.com/shaoweinuaa/NC2022_Ulcerative_colitis . Section |
data_assets.open_access |
True |
"isOpenAccess": "Y" Section |
data_assets.participant_metadata |
True |
"individual": "p1" Section |
data_assets.processed_matrix |
True |
Tab-separated values files and matrix files (barcodes.tsv, features.tsv, matrix.mtx). Section |
data_assets.raw_counts |
True |
barcodes.tsv, features.tsv, matrix.mtx Section |
Processing
| Field | Value | Evidence |
|---|---|---|
processing.batch_correction_reported |
True |
Batch effects across different individuals were removed by firstly identifying anchors using the FindIntegrationAnchors() function, followed by IntegrateData() Section |
processing.cell_type_annotation_method |
Seurat clustering and marker-based annotation |
These genes were used for cluster annotation together with known lineage-specific markers. Section |
processing.quality_control_reported |
True |
Cells with fewer than 200 and above 6000 detected genes were filtered out, as well as cells with a high proportion of mitochondrial gene counts per cell (>25%). Section |
Specimens
| Field | Value | Evidence |
|---|---|---|
specimens.anatomical_sites |
['inflamed colon region', 'normal ascending colon', 'healthy control colon'] |
Inflamed colon region; Normal ascending colon; Healthy control colon Section |
specimens.inflamed_status_available |
True |
"sample group": "UC" Section |
specimens.number_of_cells |
42952 |
42,952 single cells were captured with high sequencing quality Section |
specimens.number_of_samples |
12 |
"n_samples": 12 Section |
specimens.participant_to_sample_mapping_available |
True |
"individual": "p1" Section |
specimens.specimen_type |
biopsy |
4 pinch biopsy specimens from the healthy volunteers served as healthy control (HC group) Section |